Valeant Earnings

Shares of Valeant Pharmaceuticals Intl Inc (NYSE: VRX) rose about 14 percent early Tuesday morning after the troubled pharmaceutical company reported an encouraging first quarter earnings report and guidance raise. Valeant reported a first quarter GAAP earnings per share of $1.79, which marks an...

Shares of Valeant Pharmaceuticals Intl Inc (NYSE: VRX) hit a new 52-week low of $22.52 on Tuesday after the company released an investor presentation in conjunction with its first quarter results and conference call. Valeant earned $1.27 per share in the first quarter on revenue of $2.4 billion...